The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Flexible trial design in practice: Dropping and adding arms in STAMPEDE (MRC PR08, CRUK/06/019)—A multiarm, multistage randomized controlled trial.
Matthew Robert Sydes
Research Funding - Janssen-Cilag; Novartis; Pfizer; Sanofi
Nicholas David James
Research Funding - Janssen-Cilag; Novartis; Pfizer; Sanofi
Malcolm David Mason
Consultant or Advisory Role - Janssen-Cilag (U); Novartis (U); Pfizer (U); Sanofi (U)
Honoraria - Novartis; Pfizer; Sanofi
Research Funding - Novartis; Pfizer; Sanofi
Noel W Clarke
Research Funding - Novartis; Pfizer; Sanofi
Claire Amos
No relevant relationships to disclose
John Anderson
No relevant relationships to disclose
Johann Sebastian De Bono
Employment or Leadership Position - Institute of Cancer Research
Consultant or Advisory Role - AstraZeneca; Dendreon; Janssen-Cilag; Medivation; Sanofi
Research Funding - Janssen-Cilag
David Paul Dearnaley
Employment or Leadership Position - Institute of Cancer Research
Research Funding - Novartis; Pfizer; Sanofi
John Dwyer
No relevant relationships to disclose
Gordana Jovic
No relevant relationships to disclose
Alastair SW Ritchie
No relevant relationships to disclose
J. Martin Russell
No relevant relationships to disclose
Karen Sanders
No relevant relationships to disclose
George Thalmann
No relevant relationships to disclose
Mahesh Parmar
Honoraria - Sanofi
Research Funding - Janssen-Cilag; Novartis; Pfizer; Sanofi